Mineralocorticoid receptor ligands: Biochemical, pharmacological, and clinical aspects
- 1 November 1991
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 11 (6) , 617-639
- https://doi.org/10.1002/med.2610110604
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Treatment of Familial Male Precocious Puberty with Spironolactone and TestolactoneNew England Journal of Medicine, 1989
- Preparation of 3β,5α-, 3α,5α-and 3α,5β-tetrahydro derivatives of 19-noraldosterone by chemical synthesis and microbial bioconversionThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Different mechanisms for the receptor mediated antimineralocorticoid action of two new spirolactone derivativesBiochemical and Biophysical Research Communications, 1988
- ZK91587: A novel synthetic antimineralocorticoid displays high affinity for corticosterone (type I) receptors in the rat hippocampusLife Sciences, 1988
- Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidneyBiochemical and Biophysical Research Communications, 1987
- Evidence for an antagonist specific receptor that does not bind mineralocorticoid agonistsBiochemical and Biophysical Research Communications, 1986
- 198. 7α-Alkyl steroidal spirolactones as potent aldosterone antagonistsJournal of Steroid Biochemistry, 1982
- SpironolactoneAmerican Heart Journal, 1978
- STEROIDAL LACTONESJournal of the American Chemical Society, 1957
- Studies on the Chemistry of AldosteroneJournal of the American Chemical Society, 1955